Characterizing C9orf72 repeat expansions and transcripts using HiFi sequencing

(56:26)

How does C9orf72 expansion impact protein degradation pathways in FTLD and ALS?

(4:2)

c9ORF72

(5:36)

A novel genetic marker to detect C9orf72 repeat expansion carriers

(3:43)

Frontotemporal Dementia (FTD): Carrying the C9ORF72 Gene Mutation

(1:13)

S. Pickering-Brown - Cellular modeling of the C9orf72 repeat expansion

(25:25)

C9orf72 hexanucleotide repeat expansion in ALS and FTD

(2:31)

Estimates of C9orf72 Statistics drawn from prior publications including estimated life expectancy

(3:1econd)

How Mutation in C9ORF72 Gene Leads to Neural Disfunction and Degeneration

(23:7)

The epigenetic study of age acceleration in C9orf72 carriers

(21:43)

Antisense oligonucleotides for C9orf72-associated ALS: explaining the lack of success

(4:32)

The C9orf72 Repeat Expansion in Broad Population Screens

(55:16)

A-T and C9orf72 repeat expansion

(2:23)

V. Silani - From TARDBP and FUS/TLS to C9orf72 in ALS/FTD..

(35:18)

C. Lagier-Tourenne -Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS

(39:1econd)

Emerging role of neuroinflammation in C9orf72-ALS

(42:52)

C9ORF72 Animation

(1:26)

Long-read Sequencing to Assess an Expanded Repeat in C9orf72

(24:26)

#shorts Target ALS | The C9orf72 ALS Connection

(37)

Personalised Penetrance Estimation for C9orf72

(1:28)